Pinz Capital Management, LP Forma Therapeutics Holdings, Inc. Transaction History

Pinz Capital Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$13.6 - $24.89 $176,800 - $323,570	-13,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$21.22 - $25.7 $275,860 - $334,100	13,000 New	13,000 $301,000
Q1 2021 May 17, 2021	SELL	$24.58 - $42.82 $1.67 Million - $2.91 Million	-68,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$34.9 - $51.08 $2.37 Million - $3.47 Million	68,000 New	68,000 $2.37 Million
Q3 2020 Nov 16, 2020	SELL	$32.95 - $50.25 $978,615 - $1.49 Million	-29,700 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$39.0 - $46.49 $1.16 Million - $1.38 Million	29,700 New	29,700 $1.38 Million

26.5K

Ticker FMTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,860,400
Market Cap $958M
Description
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Pinz Capital Management, LP with notifications on news.